2030 Artificial Intelligence Pharmaceutical 
Frost & Sullivan Manufacturing
APRIL 2, 2025
Held in New York during March 17-20, 2025, the event focused on pharmaceutical innovation, industry outlook, capacity expansion, and supply chain resilience, driven by the increasing digitization of drug development and manufacturing. trillion in 2024, is expected to grow at a 7% CAGR through 2030.
Control Engineering
DECEMBER 4, 2022
Developments in hardware, software and artificial intelligence (AI) are making robots more flexible and resilient and able to perform more tasks in applications they couldnt’t before. to 2030 to reach a value of more than $88 billion. Robotics insights.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fabricating & Metal Work
MAY 26, 2023
annually from 2024 to 2031, and by 2030, it is predicted that more than 2.1 The Congressional Budget Office recently forecast that the size of the U.S. labor force will grow by just 0.2% million US manufacturing jobs will be unfilled 2.
Frost & Sullivan Manufacturing
MARCH 16, 2025
The global proteomics industry is poised for significant expansion between 2024 and 2030, driven by advances in research and pharmaceutical applications. Click here to download The post The Future of Proteomics: Innovations, Challenges, and Industry Growth (2024-2030) appeared first on Frost & Sullivan.
Frost & Sullivan Manufacturing
MARCH 28, 2025
The pharmaceutical and biotechnology industries are at the cusp of a transformative era in 2025, driven by cutting-edge innovation, evolving regulations, and increasing market pressures. By 2030, the RLT market is projected to reach $13.07 Can pharmaceutical companies balance cost-efficiency with innovation in high-value therapies?
Expert insights. Personalized for you.
52 
Let's personalize your content